Marshall Wace’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-15,969
Closed -$155K 3127
2022
Q3
$155K Sell
15,969
-106,259
-87% -$1.41M ﹤0.01% 3133
2022
Q2
$1.77M Buy
+122,228
New +$2.08M ﹤0.01% 2081
2021
Q4
Sell
-73,321
Closed -$3.67M 4026
2021
Q3
$3.67M Buy
+73,321
New +$4M 0.02% 1145
2021
Q2
Sell
-544,171
Closed -$25.5M 2806
2021
Q1
$25.5M Sell
544,171
-386,015
-41% -$18.7M 0.12% 179
2020
Q4
$40.5M Buy
930,186
+70,456
+8% +$2.6M 0.22% 97
2020
Q3
$31.5M Sell
859,730
-54,023
-6% -$1.83M 0.2% 115
2020
Q2
$26.7M Sell
913,753
-106,605
-10% -$2.95M 0.19% 122
2020
Q1
$26.7M Buy
+1,020,358
New +$31.2M 0.27% 81

Other funds holding HCAT